# K143314: Progressive Orthopaedic Total Hip System

- Pathway: 510(k) (Traditional)
- Applicant: The Progressive Orthopaedic Company, LLC
- Decided: Feb 27, 2015 after 100 days
- Product code: LPH (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented)
- Device class: 2
- Regulation: 21 CFR 888.3358
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K810258 (1981). 39 ancestors in all.
2 later devices descend from it; 2 cite it directly.
0 of 42 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K132158: Novohip Total Hip System, Novosource, Inc. (2014) Summary page 4.

## Most influential descendants
- K151424: The Progressive Orthopaedic Total Hip System (2016), 1 descendant of its own
- K192450: Precision Casting Solutions Total Hip System (2019), 0 descendants of its own

## Indications for use
The Progressive Orthopaedic Total Hip System implant components are indicated for use in cementless reconstruction of the articulating surface of femoral and/or acetabular portions of the hip that are severely disabled and/or very painful as a result of: • Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis • Rheumatoid arthritis or traumatic arthritis • Correction of functional deformity • Non-union femoral neck fracture • Trochanteric fractures of the proximal femur with head involvement which is unmanageable using other techniques. The components can be used for primary hip arthroplasty or for revision of a failed total hip arthroplasty.

Source page: https://510kreport.com/device/K143314
Methodology: https://510kreport.com/methodology